基于数据挖掘探讨龙江医派代表医家治疗 冠心病用药规律
Data Mining on Medication Patterns of Representative Physicians of Longjiang Medical School in Treating Coronary Heart Disease
DOI: 10.12677/acm.2026.1631101, PDF,    科研立项经费支持
作者: 卜亚雯, 梅婷婷*:黑龙江中医药大学第一临床医学院,黑龙江 哈尔滨
关键词: 冠心病数据挖掘龙江医派用药规律Coronary Heart Disease Data Mining Longjiang Medical School Medication Patterns
摘要: 目的:运用数据挖掘方法探讨龙江医派代表医家治疗冠心病的用药规律。方法:收集龙江医派代表医家治疗冠心病医案,利用IBM SPSS Modeler18.0、IBM SPSS Statistics27.0及中医传承辅助平台V3.5软件,对处方用药进行描述性分析、关联规则分析、聚类分析以及药物功效、性味归经等统计分析,挖掘冠心病治疗中的常用药物、核心药对、药物组合及潜在组。结果:共纳入医案163例,处方163首,常用药物以丹参、川芎、黄芪、当归等为主;药性以温性与平性为主,寒凉次之;药味以甘、苦、辛为主,主要归肝、心、脾、肺经;功效类别以补虚药与活血化瘀药为主,其次为理气药与安神药。药物间关联规则分析显示,常用药对包括降香–川芎、赤芍–川芎、醋延胡索–当归、醋香附–醋延胡索等;常用群药以丹参–川芎–黄芪、当归–川芎–赤芍等组合为代表。聚类分析结果显示,常用药物可归纳为以益气健脾、活血化瘀、益气养阴为核心治法特征的三类组方结构。结论:龙江医派代表医家治疗冠心病用药以扶正益气、活血化瘀为基本原则,配合理气止痛、通络安神之法,形成以丹参、川芎、黄芪、当归等为核心的药物配伍体系。常用药对、群药及组方体现出益气与活血并重、气血同调、标本兼顾的配伍思维,可为冠心病的中医临床辨证论治及处方优化提供数据依据。
Abstract: Objective: To investigate the medication patterns used by representative physicians of the Longjiang Medical School in the treatment of coronary heart disease (CHD) through data mining methods. Methods: Medical records of CHD treated by representative Longjiang Medical School physicians were collected. IBM SPSS Modeler 18.0, IBM SPSS Statistics 27.0, and the Traditional Chinese Medicine Inheritance Support Platform (V3.5) were applied to perform descriptive analysis, association rule analysis, cluster analysis, and statistical analyses of herbal efficacy, properties, flavors, and meridian distribution, in order to identify commonly used herbs, core herb pairs, and prescription patterns. Results: A total of 163 cases and 163 prescriptions were included. Frequently used herbs included Salvia miltiorrhiza, Ligusticum chuanxiong, Astragalus mongholicus, and Angelica sinensis. Warm and neutral herbs were predominant; sweet, bitter, and pungent flavors were most common, with herbs mainly entering the liver, heart, spleen, and lung meridians. Tonifying and blood-activating herbs were most frequently used, followed by qi-regulating and mind-calming herbs. Common herb pairs and combinations were identified, such as Salvia miltiorrhiza-Ligusticum chuanxiong-Astragalus mongholicus. Cluster analysis revealed three major prescription patterns characterized by tonifying qi and strengthening the spleen, activating blood and resolving stasis, and tonifying qi and nourishing yin. Conclusion: The treatment of CHD by Longjiang Medical School physicians is mainly based on reinforcing qi and activating blood circulation, supplemented by regulating qi, relieving pain, and calming the mind. The identified herb pairs and prescription patterns reflect a therapeutic strategy emphasizing coordinated regulation of qi and blood and consideration of both root and branch, providing a data-based reference for clinical treatment and prescription optimization of CHD in Traditional Chinese Medicine.
文章引用:卜亚雯, 梅婷婷. 基于数据挖掘探讨龙江医派代表医家治疗 冠心病用药规律[J]. 临床医学进展, 2026, 16(3): 2979-2989. https://doi.org/10.12677/acm.2026.1631101

参考文献

[1] 吴勉华. 石岩. 中医内科学[M]. 北京: 中国中医药出版社, 2021: 111.
[2] 《心肺血管病杂志》编辑部. 中国心血管健康与疾病报告2019 [J]. 心肺血管病杂志, 2020, 39(9): 1145-1156.
[3] 赵萍萍. 黄永生教授“察能化水”学术思想治疗动脉粥样硬化性疾病用药规律研究[D]: [硕士学位论文]. 长春: 长春中医药大学, 2020.
[4] 姜德友. 龙江医派学术与文化[M]. 北京: 科学出版社, 2019.
[5] 赵达, 曹晖, 胡志希. 基于关联规则和聚类分析研究全国名中医治疗冠心病用药规律[J]. 湖南中医药大学学报, 2021, 41(11): 1726-1730.
[6] 李秋实, 王瑶, 刘春红, 李文昊, 姜德友. 基于数据挖掘探讨龙江医派代表医家治疗胃痛的用药规律[J]. 亚太传统医药, 2025, 21(5): 153-158.
[7] 李秋实, 张静, 姚子胤, 姜德友. 基于数据挖掘分析姜德友教授治疗心痛的用药规律[J]. 中国医药导报, 2022, 19(15): 19-22, 28.
[8] 供名. 黄帝内经[M]. 天津: 天津古籍出版社, 2006.
[9] 宋立群. 寒地肾病的发病特点及中医药治疗的思考[J]. 中国中西医结合肾病杂志, 2022, 23(6): 471-473.
[10] 李勇军, 刘璐佳, 粱嫄, 等. 寒地儿童哮发作期的发病特点与中医论治[J]. 时珍国医国药, 2022, 33(1): 177-179.
[11] 王虎, 张依轮, 姜德友. 名中医姜德友基于寒地致病因机特色论治冠心病经验[J]. 陕西中医, 2024, 45(1): 111-114.
[12] 赵达. 基于关联规则和聚类分析研究全国名中医治疗冠心病用药规律[J]. 湖南中医药大学学报, 2021, 41(11): 1726-1730.
[13] 王惠娟, 谭颖子, 鲁翠红, 等. 冠心丹参滴丸治疗冠心病心绞痛临床疗效的Meta分析[J]. 世界中医药, 2020, 15(21): 3272-3279.
[14] Chen, L., Guo, Q., Chang, Y., Zhao, Y., Li, A. and Ji, E. (2017) Tanshinone IIA Ameliorated Endothelial Dysfunction in Rats with Chronic Intermittent Hypoxia. Cardiovascular Pathology, 31, 47-53. [Google Scholar] [CrossRef] [PubMed]
[15] Jia, L., Zhang, N., Xu, Y., Chen, W., Zhu, M., Song, N., et al. (2016) Tanshinone IIA Affects the HDL Subfractions Distribution Not Serum Lipid Levels: Involving in Intake and Efflux of Cholesterol. Archives of Biochemistry and Biophysics, 592, 50-59. [Google Scholar] [CrossRef] [PubMed]
[16] Maione, F., De Feo, V., Caiazzo, E., De Martino, L., Cicala, C. and Mascolo, N. (2014) Tanshinone IIA, a Major Component of Salvia Milthorriza Bunge, Inhibits Platelet Activation via ERK-2 Signaling Pathway. Journal of Ethnopharmacology, 155, 1236-1242. [Google Scholar] [CrossRef] [PubMed]
[17] 张晓娟, 张燕丽, 左冬冬. 川芎的化学成分和药理作用研究进展[J]. 中医药信息, 2020, 37(6): 128-133.
[18] 张萌, 高俊虹, 王玉敏, 等. 黄芪及其有效成分治疗心功能衰竭机制的研究[J]. 中医杂志, 2011, 52(4): 349-352.
[19] 候王君, 庄贺, 薛一涛. 基于中医传承辅助平台的薛一涛教授治疗冠心病的方剂组方用药规律分析[J]. 时珍国医国药, 2016, 27(10): 2508-2510.